Lower-Limb Motor Function, Mobility, Balance, Falls and Intervention Effects in Inclusion Body Myositis: A Systematic Review
Open Access
- 14 August 2026
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (16) , 6304
Abstract
Background/Objectives: Inclusion body myositis (IBM) causes progressive, quadriceps-predominant weakness that impairs mobility and increases fall risk, yet outcomes most relevant to independence remain unsynthesized for IBM. This review compiles direct IBM evidence across five domains (A1–A5): natural history, motor performance, falls and balance, sensory/peripheral-nerve function, and interventions. Methods: Eight databases and two trial registers were searched without date or language limits. Eligible studies enrolled adults with IBM based on recognized criteria reporting lower-limb strength or function, gait, transitional tasks, balance, falls, or intervention outcomes; mixed-myopathy cohorts required extractable IBM-specific data. Two reviewers independently screened, extracted, and appraised risk of bias, following PRISMA 2020. Results: Sixty-four studies were included; per-domain totals (A1: 16, A2: 9, A3: 6, A4: 2, and A5: 38) exceed 64 because studies may span domains. Quadriceps strength was the most sensitive progression marker, detected earlier by quantitative testing. Falls were near-universal and insufficiently managed. No drug showed convincing functional benefit in controlled trials, whereas exercise and orthotic/robotic assistance appeared to be safe in small studies. Sensory and peripheral-nerve dysfunction were common, but proprioceptive acuity and postural balance were unmeasured. Conclusions: IBM progression is best measured by quantitative quadriceps strength and function. Intervention evidence derives largely from small, uncontrolled and neutral trials. Primary myopathy is likely the principal driver of decline, but its downstream consequences—for balance, proprioception, and falls—remain underexplored and are the priority for future study.Keywords
This publication has 96 references indexed in Scilit:
- Inclusion body myositis in an older patient following a fallClinical Case Reports, 2023
- Evidence of nerve hypertrophy in patients with inclusion body myositis on lower limb MRIMuscle & Nerve, 2022
- Anti‐cN1A antibodies do not correlate with specific clinical, electromyographic, or pathological findings in sporadic inclusion body myositisMuscle & Nerve, 2020
- Long‐term strength and functional status in inclusion body myositis and identification of trajectory subgroupsMuscle & Nerve, 2020
- Physical function and muscle strength in sporadic inclusion body myositisMuscle & Nerve, 2017
- Treatment for inclusion body myositisCochrane Database of Systematic Reviews, 2015
- Lower Extremity Peak Force and Gait Kinematics in Individuals With Inclusion Body MyositisArthritis Care & Research, 2014
- Knee extensor strength exhibits potential to predict function in sporadic inclusion‐body myositisMuscle & Nerve, 2011
- Safety and efficacy of strength training in patients with sporadic inclusion body myositisMuscle & Nerve, 1997
- Inclusion body myositis and myopathiesAnnals of Neurology, 1995